Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference

Rhea-AI Summary

Aurinia Pharmaceuticals (NASDAQ: AUPH) announced its participation in the 2024 Cantor Fitzgerald Global Healthcare Conference in New York City from September 17-19, 2024. The company's management team will:

• Host one-on-one meetings with investors
• Participate in a fireside chat and Q&A session on Tuesday, September 17th, at 3:05 PM EDT

A live webcast of the session will be available on the Investor section of Aurinia's website. This conference provides an opportunity for Aurinia to engage with investors and showcase its developments in the healthcare sector.

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the Company’s management team will attend the 2024 Cantor Fitzgerald Global Healthcare Conference in New York City, September 17-19, 2024.

Aurinia management will host one-on-one meetings with investors and will participate in a fireside chat and Q&A session on Tuesday, September 17^th, at 3:05 PM EDT. A live webcast of the session will be available on the Investor section of Aurinia’s website, which can be found here.

About Aurinia

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, the Company introduced LUPKYNIS® (voclosporin), the first FDA-approved oral therapy dedicated to the treatment of adult patients with active lupus nephritis. Aurinia is also developing AUR200, a differentiated, potential best-in-class therapy for autoimmune diseases that targets both BAFF (B-cell Activating Factor) and APRIL (A Proliferation-Inducing Ligand).

View source version on businesswire.com: https://www.businesswire.com/news/home/20240913634435/en/

Media & Investor Inquiries:

Andrea Christopher

Corporate Communications & Investor Relations

Aurinia Pharmaceuticals Inc.

achristopher@auriniapharma.com

General Investor Inquiries:

ir@auriniapharma.com

Source: Aurinia Pharmaceuticals Inc.

FAQ

When is Aurinia Pharmaceuticals (AUPH) participating in the Cantor Fitzgerald Global Healthcare Conference?

Aurinia Pharmaceuticals (AUPH) is participating in the Cantor Fitzgerald Global Healthcare Conference from September 17-19, 2024, in New York City.

What activities will Aurinia Pharmaceuticals (AUPH) management engage in during the 2024 Cantor Fitzgerald conference?

Aurinia Pharmaceuticals (AUPH) management will host one-on-one meetings with investors and participate in a fireside chat and Q&A session on Tuesday, September 17th, at 3:05 PM EDT.

How can investors watch Aurinia Pharmaceuticals' (AUPH) presentation at the 2024 Cantor Fitzgerald conference?

Investors can watch a live webcast of Aurinia Pharmaceuticals' (AUPH) presentation, which will be available on the Investor section of Aurinia's website.

What is the significance of Aurinia Pharmaceuticals (AUPH) attending the 2024 Cantor Fitzgerald Global Healthcare Conference?

Attending the conference allows Aurinia Pharmaceuticals (AUPH) to engage with investors, showcase its developments, and potentially increase its visibility in the healthcare sector.